Anti-PD-1 Antibody Clinical Trials

7 clinical trials for Anti-PD-1 Antibody across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (B) — RECRUITING · PHASE2
• A Novel Combination Therapeutic Strategy Aiming to Functional Cure for Chronic Hepatitis B Virus Infection (Sustained HBsAg Loss) (A) — RECRUITING · PHASE2
• Sintilimab Plus Hypofractionated Radiotherapy for MSI-H/dMMR Rectal Cancer — RECRUITING · PHASE1
• Anlotinib Plus Anti-PD-1 Antibody AK105 for Advanced Pancreatic Cancer — OTHER · PHASE1
• Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial — OTHER · PHASE2
• Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy — COMPLETED · PHASE2
• Camrelizumab Combined With Chemotherapy for Recurrent or Advanced Cervical Neuroendocrine Carcinomas — OTHER · PHASE2

Refine this search